- Home
- / Guizhou Sanli Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Guizhou Sanli Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥14.1
2024-10-29
Market Capitalization
¥5.7 B
2024-10-29
Revenue
¥2.1 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 712.9M | 875.9M | 624.8M | 930.3M | 1.2B | 1.6B | 2.1B |
| Cost of goods sold | 249.8M | 298.8M | 209.0M | 277.0M | 339.5M | 436.3M | 650.0M |
| Gross profit | 463.1M | 577.2M | 415.9M | 653.4M | 850.8M | 1.2B | 1.5B |
| Gross profit margin, % | 65.9% | 66.6% | 70.2% | 71.5% | 73.1% | 69.4% | |
| Operating expense total | 357.6M | 417.3M | 303.1M | 493.9M | 601.2M | 705.8M | 1.1B |
| Depreciation and amortization | 7.6M | 7.6M | 8.1M | 11.2M | 45.9M | 210.6M | 74.8M |
| EBITDA | 106.3M | 160.5M | 114.1M | 164.1M | 260.7M | 482.9M | 408.7M |
| EBITDA margin, % | 18.3% | 18.3% | 17.6% | 21.9% | 29.8% | 19.3% | |
| EBIT | 128.6M | 153.7M | 104.4M | 159.2M | 210.3M | 278.1M | 333.9M |
| EBIT margin, % | 17.5% | 16.7% | 17.1% | 17.7% | 17.2% | 15.8% | |
| Interest income | 1.1M | 1.7M | 5.5M | 7.9M | 6.5M | 5.0M | 4.0M |
| Interest expense | 274.0K | 164.0K | 2.2M | 8.3M | 5.2M | 4.1M | 14.6M |
| Pre tax profit | 130.1M | 155.8M | 109.9M | 176.7M | 222.6M | 334.0M | 325.0M |
| Income tax expense | 19.7M | 22.7M | 15.9M | 28.0M | 30.6M | 39.2M | 45.2M |
| Net Income | 110.5M | 133.1M | 94.0M | 148.6M | 191.9M | 294.9M | 279.8M |